Protein Summary
Chemoattractant for blood monocytes, memory T-helper cells and eosinophils. Causes the release of histamine from basophils and activates eosinophils. May activate several chemokine receptors including CCR1, CCR3, CCR4 and CCR5. One of the major HIV-suppressive factors produced by CD8+ T-cells. Recombinant RANTES protein induces a dose-dependent inhibition of different strains of HIV-1, HIV-2, and simian immunodeficiency virus (SIV). The processed form RANTES(3-68) acts as a natural chemotaxis inhibitor and is a more potent inhibitor of HIV-1-infection. The second processed form RANTES(4-68) exhibits reduced chemotactic and HIV-suppressive activity compared with RANTES(1-68) and RANTES(3-68) and is generated by an unidentified enzyme associated with monocytes and neutrophils (PubMed:16791620, PubMed:1380064, PubMed:8525373, PubMed:9516414, PubMed:15923218). May also be an agonist of the G protein-coupled receptor GPR75, stimulating inositol trisphosphate production and calcium mobilizat ...more
- ENST00000603197
- ENSP00000474412
- ENSG00000271503
- ENST00000605140
- ENSP00000475057
- ENST00000613606
- ENSP00000479894
- ENSG00000274233
- ENST00000618639
- ENSP00000484921
- D17S136E
- SCYA5
- SISd
- eoCP
- SCYA5
- RANTES
- TCP228
- D17S136E
- SIS-delta
Most Knowledge About | Knowledge Value
(0 to 1 scale) | ||
---|---|---|---|
biological process | 1 | ||
biological term | 1 | ||
chemical | 1 | ||
disease | 1 | ||
molecular function | 1 | ||
Protein Classes
IDG Development Level Summary
These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 3345.93 (req: < 5)
Gene RIFs: 585 (req: <= 3)
Antibodies: 882 (req: <= 50)
These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 3345.93 (req: >= 5)
Gene RIFs: 585 (req: > 3)
Antibodies: 882 (req: > 50)
- OR - satisfy the following criterion:
Gene Ontology Terms: 79
Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions
Active Ligands: 27
Target has at least one approved drug - AND - satisfies the preceding conditions
Active Drug: 0